Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX   US23283K1051

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/24/2014 10/27/2014 10/28/2014 10/29/2014 10/30/2014 Date
0.5144(c) 0.4793(c) 0.485(c) 0.504(c) 0.543(c) Last
2 273 631 1 340 839 540 290 2 831 044 4 755 840 Volume
-3.54% -6.82% +1.19% +3.92% +7.74% Change
More quotes
Company
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects.It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device,... 
Surperformance© rating of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 17,8 M
EBIT 2014 -36,0 M
Net income 2014 -39,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 20,4 M
EBIT 2015 -11,0 M
Net income 2015 -29,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 2,25x
Capi. / Sales 2015 1,97x
Capitalization 40,1 M
More Financials
Latest news on CYTORI THERAPEUTICS INC
2d ago CYTORI THERAPEUTICS : Receives FDA Approval to Resume ATHENA Trial Enrollment
2d ago CYTORI THERAPEUTICS : Schedules Third Quarter Results Webcast
2d ago CYTORI THERAPEUTICS : Updates on Dean's Resignation
3d ago CYTORI THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
7d ago CYTORI THERAPEUTICS : to Webcast Third Quarter Financial Results on November 6
10/23 CYTORI THERAPEUTICS : Announces Closing of Financing
10/23 CYTORI THERAPEUTICS : Reports Dean's Resignation
10/23 CYTORI THERAPEUTICS : Closes Financing
10/22 CYTORI THERAPEUTICS : Receives FDA Approval to Resume ATHENA Trial Enrollment
10/21 CYTORI THERAPEUTICS : Change in Directors or Principal Officers, Financial State..
10/20 CYTORI THERAPEUTICS : Investor Note: Cytori Patents Automated Tissue Processing ..
10/20 CYTORI THERAPEUTICS : Announces Resignation of Lloyd H. Dean Effective November ..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF